Major Part Components was Guided Therapeutics’s largest product and service line in fiscal 2020, bringing in $100.00K of $102.00K (98%).
| Product and Service | FY 2017 | FY 2018 | FY 2020 |
|---|---|---|---|
| Major Part Components | — | — | $100.00K |
| Devices | $177.00K | $17.00K | — |
| Disposables | $54.00K | $32.00K | $2.00K |
| Warranty | $10.00K | $7.00K | — |
| Other | $3.00K | $1.00K | — |
| Total | $244.00K | $57.00K | $102.00K |
Guided Therapeutics brought in $102.00K from its two product and service lines in fiscal 2020, the year ended December 31, 2020. Guided Therapeutics regrouped these lines after fiscal 2018, so the total does not compare directly with that year's $57.00K. Major Part Components was the largest at $100.00K (98.0%), ahead of Disposables at $2.00K (2.0%).
Guided Therapeutics began breaking out Major Part Components in fiscal 2020, when it brought in $100.00K. Guided Therapeutics stopped reporting Devices ($17.00K in fiscal 2018), Warranty ($7.00K in fiscal 2018) and Other ($1.00K in fiscal 2018) as separate lines.
Guided Therapeutics (GTHP) reports its revenue by product and service. In fiscal 2020, Major Part Components was its largest product and service line, bringing in $100.00K (98.0% of the total), followed by Disposables at $2.00K (2.0%).
Major Part Components was Guided Therapeutics' largest product and service line in fiscal 2020, bringing in $100.00K, or 98.0% of the $102.00K total across its two product and service lines.
Every figure comes from Guided Therapeutics' annual financial filings, as reported. Each line keeps the name Guided Therapeutics gives it, and years follow its fiscal calendar.
Guided Therapeutics' revenue by product and service goes back to fiscal 2017, with figures through fiscal 2020. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.